Astrana signals at least mid-teens adjusted EBITDA growth into 2027 while forecasting 10%-15% Medicaid membership declin

Astrana Health Q3 2026 earnings: record revenue, EBITDA and cash flow, updated outlook, and key 2027 growth and Medicaid risks.